Tapinarof cream 1% once daily: Significant efficacy in atopic dermatitis in two phase 3 trials in adults and children down to age 2 years

Authors
Category Primary study
JournalJournal of Managed Care and Specialty Pharmacy
Year 2024
This article has no abstract
Epistemonikos ID: 7f9092f258afe940a5ab937f6fc16b3a726343a4
First added on: Apr 30, 2026